Andrius Žučenka, MD, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania, discusses the challenges and advancements in treating acute myeloid leukemia (AML) in patients who are unfit for intensive…
Cristina Papayannidis, MD, PhD, University of Bologna, Bologna, Italy, discusses a study evaluating the efficacy of combining venetoclax with hypomethylating agents in treating patients with acute myeloid leukemia…
NEW YORK (Reuters Health) – Results of primary percutaneous intervention (PCI) in patients with ST-segment elevation MI are better when the procedure is performed via the radial artery…
NEW YORK (Reuters Health) – Updated guidelines issued by the American Society of Clinical Oncology (ASCO) recommend that postmenopausal women with hormone receptor-positive breast cancer should receive aromatase…
NEW YORK (Reuters Health) – First-line therapy with zidovudine and interferon-alpha improves overall survival in patients with adult T-cell leukemia/lymphoma (ATL), according to the results of a retrospective…
NEW YORK (Reuters Health) – Patients with chronic heart failure have a higher mortality risk or are more likely to undergo a heart transplant if they have low…
NEW YORK (Reuters Health) – HIV-positive patients taking efavirenz are at risk for clinically significant vitamin D deficiency, and for excessive bone turnover if they are taking tenofovir,…
NEW YORK (Reuters Health) – What appears to be a blue nevus might be a cutaneous melanoma metastasis. High resolution ultrasonography can aid dermatologists in making the differential…
NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer harboring susceptibility mutations in the epidermal growth factor receptor (EGFR) did better with gefitinib given as first-line therapy…
NEW YORK (Reuters Health) – Breast cancer patients found to have micrometastases in the sentinel lymph node (SLN) but who do not undergo completion axillary lymph node dissection…
NEW YORK (Reuters Health) – In the treatment of nodular goiter, the effect of radioiodine (I-131) therapy is potentiated by neoadjuvant administration of recombinant human thyroid stimulating hormone…
NEW YORK (Reuters Health) – For locally advanced and metastatic prostate cancer, the best timing and duration of androgen-deprivation therapy (ADT) is unclear. Now, a systematic review suggests…
